Patient Advocacy and Cancer Care
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
-
Lu par :
-
De :
À propos de ce contenu audio
Theme: This briefing document explores a patient's experience navigating breast cancer treatment within the NHS and highlights the need for increased patient advocacy and improved communication within oncology teams.
Key Sources:
- Video Testimony: A husband details his wife's journey with stage three breast cancer, emphasising missed opportunities for early detection and concerns about treatment decisions, end-of-life care, and lack of exploration of alternative therapies.
- Macmillan Cancer Support Website: Information about the "Cancer Voices Community," a platform for individuals with cancer experience to share their stories and influence change in cancer care and support.
Key Ideas and Facts:
- Missed Early Detection: The husband recounts potential delays in diagnosis due to a change in his wife's mammogram being dismissed as insignificant. This raises concerns about the thoroughness of initial assessments and the importance of patient empowerment to seek second opinions or further testing.
"I believe that we should have been told, and it should have been our choice then to decide what to do next."
- Treatment Pathway Concerns: The husband expresses doubts regarding the chosen treatment pathway, suggesting that the initial chemotherapy might have exacerbated the cancer's spread. He highlights the need for oncologists to be more "agnostic" and consider a broader range of treatment options, including immunotherapy and clinical trials.
"I strongly believe that if Jane had… they would have found alternative treatments like immunotherapy or trials… to help her cope with the disease."
- End-of-Life Care Critique: The husband criticizes the heavy reliance on morphine for pain management, arguing that it potentially hastened his wife's decline. He suggests exploring alternative pain management options, like nerve blocks, to improve quality of life and potentially extend survival.
"…the end-of-life care teams need to assess that morphine is not the be-all and end-all. Morphine shortens life expectancy…"
- Call for Patient Advocacy: Both sources emphasize the need for patients to participate actively in their cancer care. The husband urges patients to challenge oncology teams, ask detailed questions about treatment plans, and explore all available options. Macmillan Cancer Support offers the "Cancer Voices Community" platform for patients to share their experiences and advocate for change within the healthcare system.
"If you are on this journey… please make sure you talk to the oncology team and understand the pathway they’re giving you. And if you feel it’s not the right pathway, question them, challenge them, and ask them for alternative treatments."
Recommendations:
- Improved Communication: Healthcare providers must clearly explain diagnostic findings and treatment options to patients, ensuring they understand the risks and benefits of each approach.
- Shared Decision-Making: Oncology teams should actively engage patients in treatment decisions, considering their preferences and circumstances.
- Early Access to Clinical Trials and Alternative Therapies: Oncology teams should proactively discuss and consider clinical trials and alternative therapies like immunotherapy alongside standard treatments.
- Comprehensive Pain Management: End-of-life care should prioritize patient comfort and explore diverse pain management strategies beyond morphine.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !